Search Results - "Stadtherr, Peter"

The Impact of Allogeneic Hematopoietic Cell Transplantation (alloHCT) on the Outcome of Poor-Risk Non-Hodgkin Lymphoma (NHL): A Retrospective Intent-to-Transplant (ITT) Analysis by Selberg, Lorenz, Stadtherr, Peter, Dietrich, Sascha, Luft, Thomas, Bondong, Andrea, Hegenbart, Ute, Meissner, Julia, Liebers, Nora, Schmitt, Michael, Mueller-Tidow, Carsten, Dreger, Peter

“…Although alloHCT is an accepted salvage treatment in defined settings of poor-risk NHL, its potential benefit in these indications remains controversial…”
Get full text

The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis by Selberg, Lorenz, Stadtherr, Peter, Dietrich, Sascha, Tran, T. Hien, Luft, Thomas, Hegenbart, Ute, Bondong, Andrea, Meissner, Julia, Liebers, Nora, Schmitt, Michael, Ho, Anthony Dick, Müller-Tidow, Carsten, Dreger, Peter

“…Purpose of this single-centre retrospective study was to assess the outcome of allogeneic hematopoietic cell transplantation (alloHCT) for relapsed/refractory…”
Get full text

CAR T cells or allogeneic transplantation as standard of care for advanced large B-cell lymphoma: an intent-to-treat comparison by Dreger, Peter, Dietrich, Sascha, Schubert, Maria-Luisa, Selberg, Lorenz, Bondong, Andrea, Wegner, Mandy, Stadtherr, Peter, Kimmich, Christoph, Kosely, Florentina, Schmitt, Anita, Pavel, Petra, Liebers, Nora, Luft, Thomas, Hegenbart, Ute, Radujkovic, Aleksandar, Ho, Anthony Dick, Müller-Tidow, Carsten, Schmitt, Michael

“…CD19-directed chimeric antigen receptor (CAR) T-cell treatment has evolved as standard of care (SOC) for multiply relapsed/refractory (R/R) large B-cell…”
Get full text

Pretransplant NPM1 -MRD Levels Predict Outcome after Allogeneic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia by Kayser, Sabine, Benner, Axel, Thiede, Christian, Martens, Uwe, Huber, Josef, Stadtherr, Peter, Janssen, Johannes W.G., Röllig, Christoph, Uppenkamp, Michael J., Bochtler, Tilmann, Hegenbart, Ute, Ehninger, Gerhard, Ho, Anthony D., Dreger, Peter, Kraemer, Alwin

“…Background: Allogeneic hematopoietic stem cell transplantation (SCT) is considered to be the treatment strategy with the highest anti-leukemic efficacy for…”
Get full text

Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell Transplantation by Schubert, Maria-Luisa, Dietrich, Sascha, Stilgenbauer, Stephan, Schmitt, Anita, Pavel, Petra, Kunz, Alexander, Bondong, Andrea, Wegner, Mandy, Stadtherr, Peter, Jung, Susanne, Ho, Anthony D., Müller-Tidow, Carsten, Schmitt, Michael, Dreger, Peter

“…•CAR T cells might be a salvage option for lymphoma relapse after alloHCT.•Information on CAR T cells in B cell lymphoma after a prior alloHCT is…”
Get full text

Bone Marrow Harvesting of Allogeneic Donors in an Outpatient Setting: A Single-Center Experience by Lisenko, Katharina, Stadtherr, Peter, Bruckner, Thomas, Pavel, Petra, Heilig, Christoph E, Schmitt, Anita, Puthenparambil, Joe, Brandt, Juliane, Ho, Anthony D, Dreger, Peter, Witzens-Harig, Mathias, Wuchter, Patrick

“…Abstract The aim of this retrospective study was to assess the safety and efficacy of bone marrow (BM) harvesting of allogeneic donors in an outpatient…”
Get full text